Back
Lucid Diagnostics, Inc. Stock Predictions
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
6
LUCD
Lucid Diagnostics, Inc.
Last Price:
$1.07
Seasonality Move:
-5.05%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLucid Diagnostics, Inc. Stock Forecast
-
Is Lucid Diagnostics, Inc. Stock Undervalued?The current Lucid Diagnostics, Inc. [LUCD] share price is $1.06. The Score for LUCD is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
LUCD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Lucid Diagnostics, Inc. Stock Go Up Next Year?
Data Unavailable
Lucid Diagnostics, Inc. Stock Rating
Data Unavailable
Lucid Diagnostics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
luciddx.com
52-Week Data
52-Week High:
1.80
52-Week Low:
0.75
Prediction Charts
Market Cap:
139M
Price in USD:
1.06
Volume:
655.7K
Beta:
1.21
Technical Analysis
SMA50:
1.12
SMA100:
1.11
SMA200:
1.21
52-Wk Change:
19.88%
Stock Predictions
-
Is Lucid Diagnostics, Inc. stock public?Yes, Lucid Diagnostics, Inc. is a publicly traded company.
-
What is the Lucid Diagnostics, Inc. stock quote today?The Lucid Diagnostics, Inc. stock price is 1.06 USD today.
-
How to buy Lucid Diagnostics, Inc. stock online?You can buy Lucid Diagnostics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 1.05 | 1.07 | 1.09 | 1.04 |
| Nov-17 | 1.05 | 1.07 | 1.10 | 1.05 |
| Nov-18 | 1.07 | 1.05 | 1.08 | 1.04 |
| Nov-19 | 1.06 | 1.02 | 1.07 | 1.02 |
| Nov-20 | 1.04 | 1.02 | 1.07 | 1.01 |
| Nov-21 | 1.02 | 1.06 | 1.07 | 1.00 |
| Nov-24 | 1.06 | 1.06 | 1.08 | 1.03 |
| Nov-25 | 1.06 | 1.09 | 1.10 | 1.03 |
| Nov-26 | 1.07 | 1.07 | 1.08 | 1.04 |
| Nov-28 | 1.06 | 1.06 | 1.10 | 1.05 |
| Dec-1 | 1.05 | 1.01 | 1.08 | 1.01 |
| Dec-2 | 1.03 | 1.01 | 1.04 | 1.01 |
| Dec-3 | 1.01 | 1.04 | 1.04 | 0.99 |
| Dec-4 | 1.04 | 1.06 | 1.07 | 1.03 |
Lucid Diagnostics, Inc. Earnings
Data Unavailable
Lucid Diagnostics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.15 per share.
* Lucid Diagnostics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.